当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2014年第33期 > 正文
编号:12706910
阿替普酶与尿激酶治疗急性心肌梗死的有效性与安全性(4)
http://www.100md.com 2014年11月25日 童随阳等
第1页

    参见附件。

     [3] Sorensen MH,Gerke O,Eugen-Olsen J,et al. Soluble urokinase plasminogen activator receptor is in contrast to high-sensitive C-reactive-protein associated with coronary artery calcifications in healthy middle-aged subjects [J]. Atherosclerosis,2014,237(1):60-66.

    [4] Geng W,Tian X,Fu X,et al. Early routine angioplasty versus selective angioplasty after successful thrombolysis in acute ST-segment elevation myocardial infarction [J]. Coron Artery Dis,2013,24(3):238-243.

    [5] Di Mario C,Dudek D,Piscione F,et al. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction(CARESS-in-AMI):an open ......

您现在查看是摘要介绍页,详见PDF附件